Investor FAQs

Investor FAQs

Show All
Where is NextCure’s corporate headquarters?
NextCure is headquartered at 9000 Virginia Manor Road, Suite 200, Beltsville, MD 20705. Our primary phone number is (240) 399-4900.
Where is the company incorporated?
NextCure is incorporated in the state of Delaware.
When did NextCure go public and how is NextCure’s stock traded?
NextCure is traded on the NASDAQ Global Market under the ticker symbol NXTC. NextCure announced the pricing of its IPO on May 8, 2019, and completed its offering on May 13, 2019.
What is NextCures’ fiscal year?
NextCure’s fiscal year ends December 31st.
Who is NextCure’s transfer agent?
The transfer agent and registrar for NextCure’s common stock is American Stock Transfer and Trust Company (AST). Contact info for AST is Phone (212) 936-5100, Toll Free (800) 937-5449, or www.amstock.com.
Who is NextCure’s registered public accounting firm?
NextCure’s independent auditor is:

Ernst & Young
1775 Tysons Blvd, Tysons, VA 22102, United States of America
Where can I find out more about NextCure?
To learn more about NextCure, please visit our website at www.nextcure.com.
Where can I get the latest corporate news releases and financial reports?
Investor- and media-related information is at ir.nextcure.com.
How can I view documents NextCure has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?
NextCure’s SEC filings are available ir.nextcure.com and www.sec.gov. Presentations, annual reports, and other investor-related materials are available at ir.nextcure.com.
Whom should I contact regarding investor inquiries?
Please direct inquiries to ir@nextcure.com.
How can I Purchase Shares?
Shares can be purchased through the broker of your choice.
What is NextCure's Committee on Uniform Security Identification Procedures (CUSIP) #?
NextCure's CUSIP # for securities is 65343E108.